🟢 Viking Therapeutics is trading 5.8% up in pre-market on continued biotech momentum

Viking Therapeutics is trading at $31.85, up 5.78%, most likely reflecting continued biotech and broader risk-on momentum after strong September 21 equity gains.

• The stock gained 3.86% on September 21.
• No new company-specific announcement was identified for September 22; Oppenheimer reiterated Outperform and a $100 price target on September 21, citing potential VK2735 maintenance-data upside.
• The move came despite a softer early pre-market tone.